Cardiol Therapeutics Inc.
CRDL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001702123
No open-market purchases or sales by Cardiol Therapeutics Inc. insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $31.3M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cardiol Therapeutics Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 32 | 35 | +3 |
| Shares | 6.77M | 7.25M | +483.1K (+7.1%) |
| Value | $3.64M | $3.54M | −$95.1K (−2.6%) |
New holders (10)
Institutions that held Cardiol Therapeutics Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AXS Investments LLC | 1,727,827 | $843.8K | 0.28% |
| Susquehanna International Group, LLP | 106,477 | $51.9K | 0.00% |
| Laird Norton Trust Company, LLC | 61,327 | $29.9K | 0.00% |
| Bank of America Corp | 60,500 | $29.5K | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 46,011 | $22.0K | 0.00% |
| Citadel Advisors LLC | 18,716 | $9.12K | 0.00% |
| Renaissance Technologies LLC | 10,100 | $5.00K | 0.00% |
| National Bank of Canada | 2,000 | $977 | 0.00% |
| The PNC Financial Services Group, Inc. | 100 | $49 | 0.00% |
| Toronto Dominion Bank | 575 | $0 | 0.00% |
Sold out (7)
Institutions that held Cardiol Therapeutics Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Mirae Asset Global Investments Co., Ltd. | 1,094,040 | $557.1K |
| Vident Investment Advisory, LLC | 146,807 | $74.8K |
| Two Sigma Securities, LLC | 33,564 | $17.1K |
| Tower Research Capital LLC (TRC) | 22,456 | $11.0K |
| StoneX Group Inc. | 10,586 | $5.40K |
| Morgan Stanley | 4,482 | $2.29K |
| Tradewinds Capital Management, LLC | 500 | $255 |